ResearcherErasmus MCActive in the last 2 years
Bernadette G. van den Hoogen
Matched on ORCID iD 0000-0003-1996-8559; OpenAlex author ID A5078395184. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 9
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 6
- Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoids. Last author DOI 10.1016/j.omton.2025.201064↗
- The use of pancreatic ductal adenocarcinoma 2D and 3D models to evaluate NDV infection, replication and induced cell death. Last author DOI 10.1038/s41598-025-06023-8↗
- Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic … Last author DOI 10.1016/j.heliyon.2022.e09915↗
- Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients? Co-author DOI 10.3390/cancers13122896↗
- Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma. Last author DOI 10.3390/v7062756↗
- Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. Last author DOI 10.1038/cgt.2013.78↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Huberts · 3 shared papers, 2022–2025 · strength 0.79
- Paper The use of pancreatic ductal adenocarcinoma 2D and 3D models to evaluate NDV infection, replication and induced cell de… DOI 10.1038/s41598-025-06023-8↗
- Paper Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma … DOI 10.1016/j.omton.2025.201064↗
- Paper Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in … DOI 10.1016/j.heliyon.2022.e09915↗
- Elham Aïda Farshadi · 2 shared papers, 2025 · strength 0.61
- Paper The use of pancreatic ductal adenocarcinoma 2D and 3D models to evaluate NDV infection, replication and induced cell de… DOI 10.1038/s41598-025-06023-8↗
- Paper Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma … DOI 10.1016/j.omton.2025.201064↗
- Casper H.J. van Eijck · 4 shared papers, 2014–2022 · strength 0.42
- Paper Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in … DOI 10.1016/j.heliyon.2022.e09915↗
- Paper Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in… DOI 10.3390/cancers13122896↗
- Paper Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Aden… DOI 10.3390/v7062756↗
- J. Fréderique de Graaf · 1 shared paper, 2022 · strength 0.17
- Willem de Koning · 1 shared paper, 2021 · strength 0.13
- Leonoor V. Wismans · 1 shared paper, 2021 · strength 0.13
- Dana A. M. Mustafa · 1 shared paper, 2021 · strength 0.13
- Pascal Buijs · 2 shared papers, 2014–2015 · strength 0.11
- Leo J. Hofland · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.